⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7633193 | 1.00 | — | — | |
| SCHEMBL27312462 | 0.82 | — | — | |
| SCHEMBL764848 | 0.78 | — | — | |
| SCHEMBL18570929 | 0.75 | — | — | |
| SCHEMBL10713098 | 0.75 | FAAH (0.31) | — | |
| SCHEMBL72617 | 0.73 | — | — | |
| SCHEMBL1352863 | 0.73 | TSHR (0.37) | — | |
| SCHEMBL8135004 | 0.73 | — | — | |
| SCHEMBL14890131 | 0.73 | — | — | |
| SCHEMBL1352862 | 0.73 | TSHR (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170313745-A1 | INHIBITORS OF HEPATITIS C VIRUS | GILEAD SCIENCES, INC. | 2017-11-02 | — | — | US | disclosed |
| US-9617310-B2 | Inhibitors of hepatitis C virus | GILEAD SCIENCES, INC. (US) | 2017-04-11 | — | — | US | disclosed |
| US-20140274884-A1 | INHIBITORS OF HEPATITIS C VIRUS | GILEAD SCIENCES, INC. | 2014-09-18 | — | — | US | disclosed |
| WO-2014145095-A1 | MACROCYCLIC AND BICYCLIC INHIBITORS OF HEPATITIS C VIRUS | GILEAD SCIENCES, INC. (US) | 2014-09-18 | — | — | WO | disclosed |
| EP-1209154-A1 | Preparation of monofluoroalkenes | Aventis CropScience GmbH (DE) | 2002-05-29 | — | — | EP | disclosed |
| WO-2002040459-A1 | PREPARATION OF MONOFLUOROALKENES | BAYER CROPSCIENCE GMBH (DE) | 2002-05-23 | — | — | WO | disclosed |